{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:29:33Z","timestamp":1791300573507,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21 AI108391"],"award-info":[{"award-number":["R21 AI108391"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.virol.2016.08.001","type":"journal-article","created":{"date-parts":[[2016,8,30]],"date-time":"2016-08-30T17:01:23Z","timestamp":1472576483000},"page":"149-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A chimeric human APOBEC3A protein with a three amino acid insertion confers differential HIV-1 and adeno-associated virus restriction"],"prefix":"10.1016","volume":"498","author":[{"given":"Yaqiong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Pramanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario L.","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward B.","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2016.08.001_bib1","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1074\/jbc.M706436200","article-title":"Vpr.A3A chimera inhibits HIV replication","volume":"283","author":"Aguiar","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2016.08.001_bib2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbrc.2014.12.103","article-title":"APOBEC3A and 3C decrease human papillomavirus 16 pseudovirion infectivity","volume":"457","author":"Ahasan","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.virol.2016.08.001_bib3","doi-asserted-by":"crossref","first-page":"e1002221","DOI":"10.1371\/journal.ppat.1002221","article-title":"APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells","volume":"7","author":"Berger","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2016.08.001_bib4","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.cub.2004.06.057","article-title":"Cytidine deamination of retroviral DNA by diverse APOBEC proteins","volume":"14","author":"Bishop","year":"2004","journal-title":"Curr. Biol."},{"key":"10.1016\/j.virol.2016.08.001_bib5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/nar\/gkj416","article-title":"APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells","volume":"34","author":"Bogerd","year":"2006","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.virol.2016.08.001_bib6","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.str.2015.03.016","article-title":"The ssDNA mutator APOBEC3A is regulated by cooperative dimerization","volume":"23","author":"Bohn","year":"2015","journal-title":"Structure"},{"key":"10.1016\/j.virol.2016.08.001_bib7","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1128\/JVI.01651-10","article-title":"Structure-function analyses point to a polynucleotide-accommodating groove essential for APOBEC3A restriction activities","volume":"85","author":"Bulliard","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.08.001_bib8","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1038\/ncomms2883","article-title":"NMR structure of human restriction factor APOBEC3A reveals substrate binding and enzyme specificity","volume":"4","author":"Byeon","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2016.08.001_bib9","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1111\/j.1558-5646.2011.01368.x","article-title":"A positively selected APOBEC3H haplotype is associated with natural resistance to HIV-1 infection","volume":"65","author":"Cagliani","year":"2011","journal-title":"Evolution"},{"key":"10.1016\/j.virol.2016.08.001_bib10","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nsmb1086","article-title":"APOBEC3G DNA deaminase Acts processively 3\u2019-5\u2019 on Single stranded DNA","volume":"13","author":"Chelico","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.virol.2016.08.001_bib11","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.cub.2006.01.031","article-title":"APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons","volume":"16","author":"Chen","year":"2006","journal-title":"Curr. Biol."},{"key":"10.1016\/j.virol.2016.08.001_bib12","doi-asserted-by":"crossref","first-page":"10522","DOI":"10.1128\/JVI.01123-06","article-title":"Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family","volume":"80","author":"Dang","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.08.001_bib13","doi-asserted-by":"crossref","first-page":"8358","DOI":"10.1128\/JVI.74.18.8358-8367.2000","article-title":"Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120","volume":"74","author":"Derdeyn","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.08.001_bib14","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.jmb.2013.10.033","article-title":"Multiple APOBEC3 Restriction Factors for HIV-1 and One Vif to Rule Them All","volume":"426","author":"Desimmie","year":"2013","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.virol.2016.08.001_bib15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.virol.2005.06.005","article-title":"Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif","volume":"339","author":"Doehle","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.virol.2016.08.001_bib16","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3389\/fmicb.2014.00450","article-title":"Suppression of APOBEC3-mediated restriction of HIV-1 by Vif","volume":"5","author":"Feng","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virol.2016.08.001_bib18","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1093\/emboj\/16.15.4531","article-title":"HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import","volume":"16","author":"Fouchier","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.virol.2016.08.001_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1742-4690-4-61","article-title":"Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity","volume":"4","author":"Goila-Gaur","year":"2007","journal-title":"Retrovirology"},{"key":"10.1016\/j.virol.2016.08.001_bib20","doi-asserted-by":"crossref","first-page":"11710","DOI":"10.1128\/JVI.01038-06","article-title":"Inhibition of tRNA3Lys-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication","volume":"80","author":"Guo","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.08.001_bib21","doi-asserted-by":"crossref","first-page":"11322","DOI":"10.1128\/JVI.00162-07","article-title":"The Interaction of APOBEC3G with human immunodeficiency virus type 1 nucleocapsid Inhibits tRNA3Lys annealing to viral RNA","volume":"81","author":"Guo","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.08.001_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/S0092-8674(03)00423-9","article-title":"DNA deamination mediates innate immunity to retroviral infection","volume":"113","author":"Harris","year":"2003","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.virol.2016.08.001_bib23","doi-asserted-by":"crossref","first-page":"e30036","DOI":"10.1371\/journal.pone.0030036","article-title":"Evolution of the primate APOBEC3A cytidine deaminase gene and identification of related coding regions","volume":"7","author":"Henry","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2016.08.001_bib24","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1093\/nar\/gkm750","article-title":"Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G","volume":"35","author":"Iwatani","year":"2007","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.virol.2016.08.001_bib25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/geno.2002.6718","article-title":"An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22","volume":"79","author":"Jarmuz","year":"2002","journal-title":"Genomics"},{"key":"10.1016\/j.virol.2016.08.001_bib26","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.virol.2014.09.001","article-title":"Cellular HIV-1 inhibition by truncated old world primate APOBEC3A proteins lacking a complete deaminase domain","volume":"468\u2013470","author":"Katuwal","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.virol.2016.08.001_bib27","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12272-014-0519-x","article-title":"The assembly of Vif ubiquitin E3 ligase for APOBEC3 degradation","volume":"38","author":"Kim","year":"2014","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.virol.2016.08.001_bib28","doi-asserted-by":"crossref","first-page":"13448","DOI":"10.1128\/JVI.00775-11","article-title":"Target cell-mediated editing of HIV-1 cDNA by APOBEC3 proteins in human macrophages","volume":"85","author":"Koning","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.08.001_bib29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.chom.2012.01.007","article-title":"Evolutionary and functional analyses of the interaction between the myeloid restriction factor SAMHD1 and the lentiviral Vpx protein","volume":"11","author":"Laguette","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virol.2016.08.001_bib30","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/embor.2011.46","article-title":"APOBEC3A can activate the DNA damage response and cause cell-cycle arrest","volume":"12","author":"Landry","year":"2011","journal-title":"EMBO Rep."},{"key":"10.1016\/j.virol.2016.08.001_bib31","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1128\/JVI.01344-09","article-title":"The range of human APOBEC3H sensitivity to lentiviral Vif proteins","volume":"84","author":"Li","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.08.001_bib32","doi-asserted-by":"crossref","first-page":"32065","DOI":"10.1074\/jbc.M703423200","article-title":"APOBEC3G inhibits DNA strand transfer during HIV-1 reverse transcription","volume":"282","author":"Li","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2016.08.001_bib33","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1128\/JVI.78.4.2072-2081.2004","article-title":"Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G","volume":"78","author":"Liu","year":"2004","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virol.2016.08.001_bib34","doi-asserted-by":"crossref","first-page":"e97062","DOI":"10.1371\/journal.pone.0097062","article-title":"A DNA sequence recognition loop on APOBEC3A controls substrate specificity","volume":"9","author":"Logue","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2016.08.001_bib35","doi-asserted-by":"crossref","first-page":"30812","DOI":"10.1074\/jbc.M112.393181","article-title":"Biochemical analysis of hypermutation by the deoxycytidine deaminase APOBEC3A","volume":"287","author":"Love","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2016.08.001_bib36","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1128\/JVI.02584-06","article-title":"Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation","volume":"81","author":"Luo","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.08.001_bib37","doi-asserted-by":"crossref","first-page":"14768","DOI":"10.1074\/jbc.270.24.14768","article-title":"Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity","volume":"270","author":"MacGinnitie","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2016.08.001_bib38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature01709","article-title":"Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts","volume":"424","author":"Mangeat","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.virol.2016.08.001_bib39","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/nm946","article-title":"HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation","volume":"9","author":"Marin","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2016.08.001_bib40","doi-asserted-by":"crossref","DOI":"10.1093\/molbev\/msw070","article-title":"Conservation and innovation of APOBEC3A restriction functions during primate evolution","author":"McLaughlin","year":"2016","journal-title":"Mol. Biol. Evol"},{"key":"10.1016\/j.virol.2016.08.001_bib41","doi-asserted-by":"crossref","first-page":"17259","DOI":"10.1074\/jbc.M602413200","article-title":"A zinc-binding region in Vif binds Cul5 and determines cullin selection","volume":"281","author":"Mehle","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2016.08.001_bib42","doi-asserted-by":"crossref","first-page":"7792","DOI":"10.1074\/jbc.M313093200","article-title":"Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway","volume":"279","author":"Mehle","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2016.08.001_bib43","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/nar\/gkt945","article-title":"Structural determinants of human APOBEC3A enzymatic and nucleic acid binding properties","volume":"42","author":"Mitra","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virol.2016.08.001_bib44","doi-asserted-by":"crossref","first-page":"22161","DOI":"10.1074\/jbc.M601716200","article-title":"APOBEC3 proteins inhibit human LINE-1 retrotransposition","volume":"281","author":"Muckenfuss","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2016.08.001_bib45","doi-asserted-by":"crossref","first-page":"e1000439","DOI":"10.1371\/journal.ppat.1000439","article-title":"Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase","volume":"5","author":"Narvaiza","year":"2009","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.virol.2016.08.001_bib46","doi-asserted-by":"crossref","first-page":"e0120089","DOI":"10.1371\/journal.pone.0120089","article-title":"APOBEC3A Is Implicated in a Novel Class of G-to-A mRNA Editing in WT1 Transcripts","volume":"10","author":"Niavarani","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2016.08.001_bib47","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1128\/JVI.80.8.3853-3862.2006","article-title":"Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H","volume":"80","author":"OhAinle","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.08.001_bib48","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.1128\/JVI.06570-11","article-title":"APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1","volume":"86","author":"Ooms","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.08.001_bib49","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1093\/molbev\/msp197","article-title":"Evolutionary trajectories of primate genes involved in HIV pathogenesis","volume":"26","author":"Ortiz","year":"2009","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.virol.2016.08.001_bib50","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1182\/blood-2006-10-051763","article-title":"Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression","volume":"110","author":"Peng","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.virol.2016.08.001_bib51","doi-asserted-by":"crossref","first-page":"8289","DOI":"10.1128\/JVI.00709-09","article-title":"Evidence that ecotropic murine leukemia virus contamination in TZM-bl cells does not affect the outcome of neutralizing antibody assays with human immunodeficiency virus type 1","volume":"83","author":"Platt","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.08.001_bib52","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1128\/MCB.22.11.3639-3652.2002","article-title":"The adeno-associated virus type 2 rep protein regulates RNA processing via interaction with the transcription template","volume":"22","author":"Qiu","year":"2002","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.virol.2016.08.001_bib53","series-title":"The Origin and Evolution of Viruses","article-title":"The role of the APOBEC3 family of cytidine deaminases in innate immunity, G to A hypermutation, and evolution of retroviruses","author":"Santiago","year":"2007"},{"key":"10.1016\/j.virol.2016.08.001_bib54","doi-asserted-by":"crossref","first-page":"E275","DOI":"10.1371\/journal.pbio.0020275","article-title":"Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G","volume":"2","author":"Sawyer","year":"2004","journal-title":"PLoS Biol."},{"key":"10.1016\/j.virol.2016.08.001_bib55","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.virol.2011.07.017","article-title":"Differential virus restriction patterns of rhesus macaque and human APOBEC3A: implications for lentivirus evolution","volume":"419","author":"Schmitt","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.virol.2016.08.001_bib56","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.virol.2013.04.002","article-title":"Lentivirus restriction by diverse primate APOBEC3A proteins","volume":"442","author":"Schmitt","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.virol.2016.08.001_bib57","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1038\/ncomms7881","article-title":"APOBEC3A cytidine deaminase induces RNA editing in monocytes and macrophages","volume":"6","author":"Sharma","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2016.08.001_bib58","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/nm945","article-title":"The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif","volume":"9","author":"Sheehy","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2016.08.001_bib59","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nature00939","article-title":"Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein","volume":"418","author":"Sheehy","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.virol.2016.08.001_bib61","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.1128\/jvi.71.7.5259-5267.1997","article-title":"The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells","volume":"71","author":"Simon","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.08.001_bib63","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/A:1025732728195","article-title":"Quantitative analysis of human immunodeficiency virus type 1 DNA dynamics by real-time PCR: integration efficiency in stimulated and unstimulated peripheral blood mononuclear cells","volume":"27","author":"Suzuki","year":"2003","journal-title":"Virus Genes"},{"key":"10.1016\/j.virol.2016.08.001_bib64","doi-asserted-by":"crossref","first-page":"12585","DOI":"10.1128\/JVI.01726-08","article-title":"Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research","volume":"82","author":"Takeuchi","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.08.001_bib65","doi-asserted-by":"crossref","first-page":"27753","DOI":"10.1074\/jbc.M110.102822","article-title":"Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms","volume":"285","author":"Thielen","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2016.08.001_bib66","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1126\/science.1153201","article-title":"Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions","volume":"320","author":"Vartanian","year":"2008","journal-title":"Science"},{"issue":"Oct","key":"10.1016\/j.virol.2016.08.001_bib67","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12985-016-0469-7","article-title":"The role of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer","volume":"2015","author":"Wang","year":"2016","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2016.08.001_bib68","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1128\/JVI.02383-14","article-title":"APOBEC3A functions as a restriction factor of human papillomavirus","volume":"89","author":"Warren","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.08.001_bib69","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/AAC.46.6.1896-1905.2002","article-title":"Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy","volume":"46","author":"Wei","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2016.08.001_bib70","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1038\/sj.emboj.7600246","article-title":"A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins","volume":"23","author":"Wiegand","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.virol.2016.08.001_bib71","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.mam.2010.06.001","article-title":"HIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factors","volume":"31","author":"Wichroski, M.J., Ichiyama, K., Rana, T.M., 2005. Analysis of HIV-1 viral infectivity factor-mediated proteasome-dependent depletion of APOBEC3G: correlating function and subcellular localization. J. Biol. Chem. 280, 8387\u20138396.Wissing","year":"2010","journal-title":"Mol. Asp. Med. Oct."},{"key":"10.1016\/j.virol.2016.08.001_bib72","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","article-title":"Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenvirus","volume":"72","author":"Xiao","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.08.001_bib73","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.virol.2006.02.002","article-title":"Assembly of HIV-1 Vif-Cul5 E3 ubiquitin ligase through a novel zinc-binding domain-stabilized hydrophobic interface in Vif","volume":"349","author":"Xiao","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.virol.2016.08.001_bib74","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.virol.2007.03.022","article-title":"Inhibition of initiation of reverse transcription in HIV-1 by human APOBEC3F","volume":"365","author":"Yang","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.virol.2016.08.001_bib75","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nsmb758","article-title":"Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome","volume":"11","author":"Yu","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.virol.2016.08.001_bib76","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1126\/science.1089591","article-title":"Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex","volume":"302","author":"Yu","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.virol.2016.08.001_bib77","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature01707","article-title":"The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA","volume":"424","author":"Zhang","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.virol.2016.08.001_bib78","doi-asserted-by":"crossref","first-page":"6073","DOI":"10.1128\/JVI.78.11.6073-6076.2004","article-title":"Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication","volume":"78","author":"Zheng","year":"2004","journal-title":"J. Virol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682216302082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682216302082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:37:53Z","timestamp":1758587873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682216302082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":75,"alternative-id":["S0042682216302082"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2016.08.001","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A chimeric human APOBEC3A protein with a three amino acid insertion confers differential HIV-1 and adeno-associated virus restriction","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2016.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}